SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ambar Protein Industries Ltd (519471)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 519471 NSE: Edible Oil | Small Cap | Ambar Protein Share Price

₹185 -7.95 (-4.12%)

As on 04-Jun'26 16:59

Ambar Protein Industries Ltd (519471)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 519471 NSE: Edible Oil | Small Cap | Ambar Protein Share Price

₹185 -7.95 (-4.12%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹106 Cr.
Current Price
₹185
52-Week Low / High
₹145 / 433
TTM EPS
₹12.2
TTM Sales
₹501 Cr.
Book Value per Share
₹72.6
P/E Ratio
15.14
Lower than its 5-year historical median
Industry PE
36.9
Price to Book (P/B)
2.55
Lower than its 5-year historical median
Price to Sales (P/S)
0.21
Lower than its 5-year historical median
EV/EBITDA
10.25
Lower than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
32.28%
Outperforms industry median
Return on Capital Employed (ROCE)
27.50%
Outperforms industry median
Return on Assets (ROA)
14.63%
Operating Profit Margin
3.7%
Net Profit Margin
2.29%
Gross Profit Margin
3.4%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
25.02%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
113.4%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
206.35%
Asset Quality
Promoter Holding
72.69%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹36 Cr.
Equity
₹5.8 Cr.
Face Value
₹10
All Time Low / High
₹2.00 / 843.50

Ambar Protein Industries stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Somewhat Good

Valuation

Somewhat Undervalued

Price Trend

Weak
Q.1 Is Ambar Protein Industries Ltd a good quality company?
Ambar Protein Industries Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Ambar Protein Industries Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Ambar Protein Industries Ltd vs industry peers?
Ambar Protein Industries Ltd revenue CAGR is 8.20%, compared to the industry median CAGR of 4.81%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Ambar Protein Industries Ltd?
Promoters hold 72.69% of the Ambar Protein Industries Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Ambar Protein Industries Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 92.91% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Ambar Protein Industries Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 18.7%22.2%17.5%13.4%14.8%16.5%18.3%12.6%12.9%27.5%-
Value Creation
Index
0.30.60.30.00.10.20.3-0.1-0.11.0-

Growth Parameters

Sales 168195206231284313340345337422501
Sales YoY Gr.-15.9%5.5%11.9%23.3%10.2%8.4%1.6%-2.3%25%-
Adj EPS 1.54.23.83.52.26.67.74.95.516.812.2
YoY Gr.-185%-10.5%-5.6%-37.9%199.1%17.6%-36.8%11.9%206.8%-
BVPS (₹) 8.51013.817.319.525.533.238.143.660.472.6
Adj Net
Profit
0.82.42.221.33.84.52.83.29.77
Cash Flow from Ops. -0.7-2.50.81.131.1-2.56.272.2-
Debt/CF from Ops. -9.1-4.122.223.18.924.8-134.73.712-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 10.7%8.2%7.5%25%
Adj EPS 31.1%50.1%29.4%206.8%
BVPS24.4%25.4%22.1%38.5%
Share Price - 92.5% -6.9% -12.7%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
16.640.231.522.81229.326.413.713.432.318.4
Op. Profit
Mgn %
1.21.31.51.72.12.52.72.12.23.72.4
Net Profit
Mgn %
0.51.21.10.90.51.21.30.80.92.31.4
Debt to
Equity
1.11.82.32.52.41.91.71.310.80
Working Cap
Days
1723273635303744443919
Cash Conv.
Cycle
61314192018242929287

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales168195206231284313340345337422
Operating Expenses + 167193203227278306331338330406
Manufacturing Costs12121212121518182019
Material Costs152178188212263288308315304381
Employee Cost 1111111111
Other Costs 2232223354
Operating Profit 23346797716
Operating Profit Margin (%) 1.2%1.3%1.5%1.7%2.1%2.3%2.7%2.1%2.2%3.7%
Other Income + 0110001101
Exceptional Items 0000000000
Interest 1111333322
Depreciation 0000111111
Profit Before Tax 12333464413
Tax 1011211113
Profit After Tax 12221343310
PAT Margin (%) 0.5%1.2%1.1%0.9%0.4%1.1%1.3%0.8%0.9%2.3%
Adjusted EPS (₹)1.54.23.83.52.26.07.74.95.516.8
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Ambar Protein - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 66810111519222535
Share Capital 7666666666
Reserves -10245913161929
Debt +6101824272733292626
Long Term Debt0045443200
Short Term Debt6101420232430282526
Minority Interest0000000000
Trade Payables5536247674
Others Liabilities -12213955546
Total Liabilities 17233153495064626171

Fixed Assets

Net Fixed Assets +6667222121201918
Gross Block12121313302728292929
Accumulated Depreciation66678679911
CWIP 00616000001
Investments 0000000000
Inventories89822141727192020
Trade Receivables1411239141420
Cash Equivalents 1231321111
Others Assets 1167866779
Total Assets 17233153495064626171

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -1-31131-3672
PBT 12333464413
Adjustment 1001344333
Changes in Working Capital -3-5-1-2-2-6-1110-11
Tax Paid 00-1-1-1-1-1-2-1-3
Cash Flow From Investing Activity + -10-5-10-1-0-00-0-0
Capex -1-1-6-11-1-1-1-1-1-1
Net Investments 00-00-1-0-00-0-0
Others 0110011101
Cash Flow From Financing Activity + 1367-0-22-6-7-2
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0041-1-0-1-1-1-0
Interest Paid -1-1-1-1-3-3-3-3-2-2
Dividend Paid 0000000000
Others 1428316-3-31
Net Cash Flow -111-21-1-00-00

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)23.8245.2431.522.7611.7926.6926.3813.7213.3932.28
ROCE (%)18.6922.1717.4513.3814.8416.5318.3312.5912.9127.5
Asset Turnover Ratio11.429.857.645.495.556.295.945.465.456.39
PAT to CFO Conversion(x)-1-1.50.50.530.33-0.7522.330.2
Working Capital Days
Receivable Days2.305.405.202.302.303.206.7012.4015.3014.80
Inventory Days13.1015.9015.7023.7023.1018.5023.7024.4021.4017.50
Payable Days10.109.407.207.605.803.806.407.9085

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ambar Protein Industries Ltd FAQs

The current trading price of Ambar Protein on 04-Jun-2026 16:59 is ₹185.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Ambar Protein stood at ₹106.4 Cr

The latest P/E ratio of Ambar Protein as of 03-Jun-2026 is 15.14.

The latest P/B ratio of Ambar Protein as of 03-Jun-2026 is 2.55.

The 52-week high of Ambar Protein is ₹432.9 and the 52-week low is ₹145.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ambar Protein is ₹501 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Ambar Protein Industries Ltd is a average quality company.

The key valuation ratios of Ambar Protein Industries Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Ambar Protein Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Ambar Protein Industries Ltd

Ambar Protein Limited is a company incorporated on December 31, 1992 with the basic object of manufacturing Edible/ Non Edible Oils, Oil Cakes and 'D' Oil Cake having registered office at Sarkhej - Bavla Highway, Opp. Bhagyoday Hotel, Changodar, Ahmedabad Gujarat.

Business area of the company

Presently the company has dealing in segment of refining cotton seed oil and trading and also purchased & packed Refined Cottonseed, Groundnut Oil, Refined Sunflower, Refined Maize Oil and Soybean Oil for resale.

You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×